Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93,104,451
-
Total 13F shares
-
79,888,231
-
Share change
-
+1,466,638
-
Total reported value
-
$1,451,741,809
-
Put/Call ratio
-
21%
-
Price per share
-
$18.17
-
Number of holders
-
185
-
Value change
-
+$19,085,207
-
Number of buys
-
89
-
Number of sells
-
83
Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q2 2022
As of 30 Jun 2022 MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) had 185 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 79,888,231 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, EARNEST PARTNERS LLC, WELLINGTON MANAGEMENT GROUP LLP, Camber Capital Management LP, STATE STREET CORP, BANK OF AMERICA CORP /DE/, DIMENSIONAL FUND ADVISORS LP, Artisan Partners Limited Partnership, and D. E. Shaw & Co., Inc..
This table shows 185 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.